Skip to content

Vitamin D Supplement for Patients With Tibial Fracture

Vitamin D Supplement for Patients With Tibial Fracture Treated With an External Ring Fixator. A Prospective Randomized Double-blind Study.

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01955577
Enrollment
130
Registered
2013-10-07
Start date
2015-04-30
Completion date
2016-12-31
Last updated
2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tibial Fracture

Keywords

Vitamin D deficiency, Ring fixator, Tibial fracture

Brief summary

The purpose is to study: 1. the frequency of vitamin D deficiency at patients with tibial fracture treated with an external ring fixator 2. if vitamin D supplement facilitates fracture healing 3. a possible relation between vitamin D deficiency and the risk of complications and the time of fracture healing

Detailed description

External ring fixator is a widespread and well-known method to treate complex tibial fractures. The effect of treating proximal and distal intra-articulatio tibial fractures has been positive until now. Complications such as malunions, nonunions, re-fractures and extended time of ring fixation will occur in 5-10% of all tibial fractures in patients treated with ring fixator. Factors like trauma of soft tissue, smoking and compromised afflux of blood are associated with a higher frequency of nonunion. It has been documented that elderly people with hypovitaminosis D have a higher risk of being affected by osteoporosis and fractures. Furthermore, there is a possible association between the severity of fracture and hypovitaminosis. The time of fracture healing is also extended compared to fractures in patients who are not affected by osteoporosis. Until now research has not shown whether the fracture healing process is influenzed by vitamin D.

Interventions

Sponsors

Northern Orthopaedic Division, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patients with tibial fracture * A written signed statement of consent * All potential patients primary with osteosynthesis Iliazov

Exclusion criteria

* Tumours in bone * Metastases to bone marrow * Chronic renal disease * Drug abuse * Abuse of alcohol (\>21 drinks a week for men and \> 14 drinks a week for women) * Morbus Cushing disease * Glandulae thyroid disease * Pregnancy * Chronic steroid therapy * Hepatic insufficiency * Sarcoidosis, tuberculosis or silocosis * Patients under 18 years * Inability to take medicine * Adverse effects of vitamin D or allergic to vitamin D

Design outcomes

Primary

MeasureTime frameDescription
Time of fracture healing20 weeksTime of fracture healing, i.e. time from osteosynthesis until fracture healing is clinically and radiologically registered.

Secondary

MeasureTime frameDescription
Vitamin D receptor DNA20 weeksA DNA blood sample will be taken in order to analyse how the skeleton reacts on vitamin D supplement.
Complications20 weeksRegistration of possible complications, i.e. nonunion, malunion, number of check-ups, infections, re-surgery.

Countries

Denmark

Contacts

Primary ContactChristian Cavallius, M.D.
christian.cavallius@rn.dk
Backup ContactJuozas Petruskevicius, M.D., Ph.D.
juope@rn.dk99 32 52 40

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026